Nanobiotix S.A. (EPA:NANO)
18.28
-0.38 (-2.04%)
At close: Dec 5, 2025
Nanobiotix Employees
Nanobiotix had 108 employees as of December 31, 2024. The number of employees increased by 6 or 5.88% compared to the previous year.
Employees
108
Change (1Y)
6
Growth (1Y)
5.88%
Revenue / Employee
€98,631
Profits / Employee
€501,388
Market Cap
881.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| Sanofi | 82,878 |
| Sartorius Stedim Biotech | 9,901 |
| bioMérieux | 14,754 |
| Eurofins Scientific SE | 62,696 |
| Ipsen | 5,358 |
| ABIVAX Société Anonyme | 69 |
| Virbac | 6,365 |
Nanobiotix News
- 11 days ago - Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook - GlobeNewsWire
- 12 days ago - Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue - The Motley Fool
- 22 days ago - NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations - GlobeNewsWire
- 4 weeks ago - NANOBIOTIX to Participate in Investor Conferences the Week of November 10th - GlobeNewsWire
- 5 weeks ago - Nanobiotix (NBTX) Secures $71M Financing Deal with HealthCare Royalty - GuruFocus
- 5 weeks ago - NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth - GlobeNewsWire
- 2 months ago - Nanobiotix (NBTX) Sees Stock Rise on Promising Cancer Drug Trial Results - GuruFocus
- 2 months ago - Nanobiotix gains after early-stage trial data for J&J-partnered cancer drug - Seeking Alpha